Diseases of the Glomerular Filtration Barrier. Alport Syndrome and Congenital Nephrosis (NPHS1).

The Kidney: From Normal Development to Congenital Disease

Volumn , Issue , 2003, Pages 475-486

  Jalanko, Hannu ^a   Holmberg, Christer ^a   Tryggvason, Karl ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 20744451285     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012722441-1/50029-4     Document Type: Chapter

References (84)

1. Ahola H., Wang S.W., Luimula P., Solin M.-L., Holzman L., Holthöfer H. Cloning and expression of the rat nephrin homolog. Am. J. Pathol. 1999, 155:907-913.
2. Alport A.C. Hereditary familial congenital haemorrhagic nephritis. Br. Med. J. 1927, 1927:1504-1506.
3. Antignac C., Zhou J., Sanak M., Cochat P., Roussel B., Deschenes G., Knebelman B., Hors M.C., Tryggvason K., Gubler M.-C. Alport syndrome and diffuse leiomyomatosis: Deletions in the 5' end of the COL4A5 collagen gene. Kidney Int. 1992, 42:1178-1183.
4. Atkin C.L., Gregory M.C., Border W.A. Alport syndrome. Diseases of Kidney 1988, 617-641. Little-Brown, New York. W. Schrier, C. Gottschalk (Eds.).
5. Aula P., Rapola J., Karjalainen O., Seppälä M. Prenatal diagnosis of congenital nephrosis in 23 high-risk families. Am. J. Dis. Child. 1978, 132:984-987.
6. Aya K., Tanaka H., Seino Y. Novel mutation in the nephrin gene of a Japanese patient with congenital nephrotic syndrome of the Finnish type. Kidney Int. 2000, 57:401-404.
7. Barker D.E., Hostikka S.L., Zhou J., Show L.T., Oliphant A.R., Gergen S.C., Gregory M.C., Skolnick M.H., Atkin C.L., Tryggvason K. Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 1990, 248:1224-1227.
8. Beltcheva O.J., Lenkkeri U., Kestilä M., Mannikko M., Tryggvason K. Spectrum of nephrin gene mutations in congenital nephrotic syndrome. J. Am. Soc. Nephrol. 1999, 10:A2172.
9. Bolk S., Puffenberger E.G., Hudson J., Morton D.H., Chakravarti A. Elevated frequency and allelic heterogeneity of congenital nephrotic syndrome, Finnish type, in the old order Mennonites. Am. J. Hum. Genet. 1999, 65:1785-1790.
10. Boutaud A., Borza D.-B., Bondar O., Gunwar S., Netzer K.-O., Singh N., Ninomiya Y., Sado Y., Noelken M., Hudson B. Type IV collagen of the glomerular basement membrane: Evidence that the chain specificity of network assembly is encoded by the noncollagenous NC1 domains. J. Biol. Chem. 2000, 275:30716-30724.
11. Boute N., Gribouval O., Roselli S., Benessy F., Lee H., Fuchshuber A., Dahan K., Gubler M.-C., Niaudet P., Antignac C. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nature Genet. 2000, 24:349-355.
12. Cosgrove D., Rodgers K., Meehan D., Miller C., Bovard K., Gilroy A., Gardner H., Kotelianski V., Gotwals P., Amatucci A., Kalluri R. Integrin α1β1 and transforming growth factor-β1 play distinct roles in Alport glomerular pathogenesis and serve as dual targets for metabolic therapy. Am. J. Pathol. 2000, 157:1649-1659.
13. Dahan K., Heidet L., Zhou J., Mettler G., Leppig K.A., Proesman W., David A., Roussel B., Mongeau J.G., Gould J., Grunfeld J.-P., Gubler M.-C., Antignac C. Smooth muscle tumors associated with X-linked Alport syndrome: Carrier detection in females. Kidney Int. 1995, 48:1900-1906.
14. Guez S., Giani M., Melzi M., Antignac C., Assael B. Adequate clinical control of congenital nephrotic syndrome by enalapril. Pediatr. Nephrol. 1998, 12:130-132.
15. Gunwar S., Ballester F., Noelken M.E., Sado Y., Ninomiya Y., Hudson B.G. Glomerular basement membrane. Identification of a novel disulfide-cross-linked network of α3, α4 and α5 chains of type IV collagen and its implications for the pathogenesis of Alport syndrome. J. Biol. Chem. 1998, 273:8767-8775.
16. Hallman N., Hjelt L., Ahvenainen E.K. Nephrotic syndrome in newborn and young infants. Ann. Paediatr. Fenn. 1956, 2:227-241.
17. Harvey S.J., Zheng K., Sado Y., Naito I., Ninomiya Y., Jacobs R.M., Hudson B.G., Thorner P.S. Role of distinct type IV collagen networks in glomerular development and function. Kidney Int. 1998, 54:1857-1866.
18. Heaton P.A., Smales O., Wong W. Congenital nephrotic syndrome responsive to captopril and indomethacin. Arch. Dis. Child. 1999, 81:174-175.
19. Heidet L., Cai Y., Guicharnaud L., Antignac C., Gubler M.-C. Glomerular expression of type IV collagen chains in normal and X-linked Alport syndrome kidneys. Am. J. Pathol. 2000, 156:1901-1910.
20. Heidet L., Dahan K., Zhou J., Xu Z., Cochat P., Gould J.D., Leppig K.A., Proesmans W., Guyot C., Guillot M., et al. Deletions of both alpha 5(IV) and alpha 6(IV) collagen genes in Alport syndrome and in Alport syndrome associated with smooth muscle tumours. Hum. Mol. Gen. 1995, 4:99-108.
21. Heikkilä P., Parpala T., Lukkarinen O., Weber M., Tryggvason K. Adenovirus-mediated gene transfer into kidney glomeruli using an ex vivo and in vivo kidney perfusion system: First steps towards gene therapy of Alport syndrome. Gene Ther. 1996, 3:21-27.
22. Holmberg C., Jalanko H., Tryggvason K., Rapola J. Congenital nephrotic syndrome. Pediatric Nephrology 1999, 765-777. Lippincott Williams & Wilkins, Boston. 4th Ed. T. Barratt, E. Avner, W. Harmon (Eds.).
23. Holzman L.B., St.John P.L., Kovari I.A., Verma R., Holthöfer H., Abrahamson D.R. Nephrin localizes to the slit pore of the glomerular epithelial cells. Kidney Int. 1999, 56:1481-1491.
24. Holthöfer H., Ahola H., Solin M.-L., Wang S., Palmen T., Luimula P., Miettinen A., Kerjaschki D. Nephrin localizes at the podocyte filtration slit area and is characteristically spliced in the human kidney. Am. J. Pathol. 1999, 155:1681-1687.
25. Hudson B.G., Reeders S.T., Tryggvason K. Type IV collagen: Structure, gene organization, and role in human diseases: Molecular basis of Goodpasture and Alport syndromes and diffuse leiomyomatosis. J. Biol. Chem. 1993, 268:26033-26036.
26. Huttunen N.-P. Congenital nephrotic syndrome of Finnish type: Study of 75 patients. Arch. Dis. Child. 1976, 51:344-348.
27. Huttunen N.-P., Rapola J., Vilska J., Hallman N. Renal pathology in congenital nephrotic syndrome of Finnish type: A quantitative light microscopic study on 50 patients. Int. J. Pediatr. Nephrol. 1980, 1:10-16.
28. Jais J., Knebelman B., Giatras I., Marchi M., Rizzoni G., et al. X-linked Alport syndrome: Natural history in 195 families and genotype-phenotype correlations in males. J. Am. Soc. Nephrol. 2000, 11:649-657.
29. Jansen B., Thorner P., Baumal R., Valli V., Maxie M.G., Singh A. Samoyed hereditary glomerulopathy (SHG): Evolution of splitting of glomerular capillary basement membranes. Am. J. Pathol. 1986, 125:536-545.
30. Jefferson J.A., Lemmink H.H., Hughes A.E., Hill C.M., Smeets H.J.M., Doherty C.C., Maxwell A.P. Autosomal dominant Alport syndrome linked to the type IV collagen α3 and α4 genes (COL4A3 and COL4A4). Nephr. Dial. Transpl. 1997, 12:1595-1599.
31. Kalluri R., Gattone V.H., Noelken M.E., Hudson B.G. The alpha 3 chain of type IV collagen induces autoimmune Goodpasture syndrome. Proc. Natl. Acad. Sci. USA 1994, 91:6201-6205.
32. Kalluri R., Shield C.F., Todd P., Hudson B.G., Neilson C. Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis. J. Clin. Invest. 1997, 99:2470-2478.
33. Kanwar Y.S., Farquhar M.G. Presence of heparan sulfate in the glomerular basement membrane. Proc. Natl. Acad. Sci. USA 1979, 76:1303-1307.
34. Kanwar Y.S., Liu Z.Z., Kashihara N., Wallner E.I. Current status of the structural and functional basis of glomerular filtration and proteinuria. Semin. Nephrol. 1991, 11:390-413.
35. Kaplan J.M., Kim S.H., North K.N., Rennke H., Correia L.A., Tong H.-Q., Mathias B.J., Rodriquez-Perez J.-C., Allen P.G., Beggs A.H., Pollak M.R. Mutations in ACTN4, encoding α-actinin-4, cause familial focal segmental glomerulosclerosis. Nature Genet. 2000, 24:251-256.
36. Kashtan C. Glomerular disease. Semin. Nephrol. 1999, 19:353-363.
37. Kashtan C., Kim Y. Distribution of the α1 and α2 chains of collagen type IV and of collagens V and VI in Alport syndrome. Kidney Int. 1992, 42:115-126.
38. Kawachi H., Koike H., Kurihara H., Yaoite E., Orikasa M., Shia M.A., Sakai T., Yamamoto T., Salant D.J., Shimizu F. Cloning of rat nephrin: Expression on developing glomeruli and in proteinuric states. Kidney Int. 2000, 57:1949-1961.
39. Kestilä M., Lenkkeri U., Männikkö M., Lamerdin J., McCready P., Putaala H., Ruotsalainen V., Morita T., Nissinen M., Herva R., Kashtan C.E., Peltonen L., Holmberg C., Olsen A., Tryggvason K. Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Mol. Cell 1998, 1:575-582.
40. Kestilä M., Männikkö M., Holmberg C., Gyapay G., Weissenbach J., Savolainen E., Peltonen L., Tryggvason K. Congenital nephrotic syndrome of the Finnish type maps to the long arm of chromosome 19. Am. J. Hum. Genet. 1994, 54:757-764.
41. Kneblemann B., Breillat C., Forestier L., Arrondel C., Jacassier D., Giatras I., Drouot L., Deschnes G., Grunfeld J.-P., Broyer M., Gubler M.-C., Antignac C. Spectrum of mutations in the COL4A5 collagen gene in X-linked Alport syndrome. Am. J. Hum. Genet. 1996, 59:1221-1232.
42. Koziell A.B., Lenkkeri U., Grech V., Trompeter R.S., Barrat T.M., Tryggvason K. Nephrin mutations in congenital nephrotic syndrome: Further evidence for a critical role in the pathogensis of proteinuria. J. Am. Soc. Nephrol. 1999, 10:A2205.
43. Koziell A., Lenkkeri U., Grech U., Tryggvason K. NPHS1 gene mutations in Finnish type congenital nephrotic syndrome patients of non-Finnish origin. Pediatr. Nephrol. 1999, 13:C24.
44. Laine J., Jalanko H., Holthöfer H., Krogerus L., Rapola J., von Willebrand E., Lautenschlager I., Salmela K., Holmberg C. Post-transplantation nephrosis in congenital nephrotic syndrome of the Finnish type. Kidney Int. 1993, 44:867-874.
45. Lee H.J., Gribouval O., Antignac C. NPHS1 Mutations in non-Finnish CNF populations. J. Am. Soc. Nephrol. 1999, 10:A2206.
46. Lees G.E., Wilson P.D., Helman R.G., Homco L.D., Frey M.S. Glomerular ultrastructural findings similar to hereditary nephritis in 4 English cocker spaniels. J. Vet. Int. Med. 1997, 11:80-85.
47. Lemmink H.H., Niilesen W.N., Mochizuki T., Schröder C.H., Brunner H.G., van Oost B.A., Monnens L.A.H., Smeets H.J.M. Benign familial hematuria due to mutation of the type IV collagen α4 gene. J. Clin. Invest. 1996, 98:1114-1118.
48. Lenkkeri U., Männikkö M., McCready P., Lamerdin J., Gribouval O., Niaudet P., Antignac C., Kashtan C., Holmberg C., Olsen A., Kestilä M., Tryggvason K. Structure of the gene for congenital nephrotic syndrome of the Finnish type (NPHS1) and characterization of mkutations. Am. J. Hum. Genet. 1999, 64:51-61.
49. Ljungberg P., Holmberg C., Jalanko H. Infections in infants with congenital nephrosis of the Finnish type. Pediatr. Nephrol. 1997, 11:148-152.
50. Lu W., Phillips C.L., Pverbeekt P., Meisler M.H., Killen P.D. A new model of Alport's syndrome. J. Am. Soc. Nephrol. 1997, 8:1818A.
51. Mazzucco G., Barsotti P., Muda A.O., Fortunato M., Mihatsch M., Torri-Tarelli L., Renieri A., Faraggiana T., de Marchi M., Monga G. Ultrastructural and immunohistochemical findings in Alport's syndrome: A study of 108 patients from 97 Italian families with particular emphasis on COL4A5 gene mutation correlations. J. Am. Soc. Nephrol. 1998, 9:1023-1031.
52. Miner J.H., Sanes J.R. Molecular and functional defects in kidneys of mice lacking collagen α3(IV): Implications for Alport syndrome. J. Cell. Biol. 1996, 135:1403-1413.
53. Mochizuki T., Lemmink H.H., Mariyama M., Antignac C., Gubler M.-C., Pirson Y., Verellen-Dumoulin C., Chan B., Schröder C.H., Smeets H.J., Reeders S.T. Identification of mutations in the α3(IV) and α4(IV) collagen genes in autosomal recessive Alport syndrome. Nature Genet. 1994, 8:77-82.
54. Moeller M.J., Kovari I.A., Holzman L.B. Evaluation of a new tool for exploring podocyte biology: Mouse NPHS1 5' flanking region drives lacZ expression in podocytes. J. Am. Soc. Nephrol. 2000, 11:2306-2314.
55. Männikkö M., Kestilä M., Holmberg C., Norio R., Ryynänen M., Olsen A., Peltonen L., Tryggvason K. Fine mapping and haplotype analysis of the locus for congenital nephrotic syndrome on chromosome 19 q 13.1. Am. J. Hum. Genet. 1995, 57:1377-1383.
56. Männikkkö M., Kestilä M., Lenkkeri U., Alakurtti H., Holmberg C., Leisti J., Salonen R., Aula P., Mustonen A., Peltonen L., Tryggvason K. Improved prenatal diagnosis of the congenital nephrotic syndrome of the Finnish type based on DNA analysis. Kidney Int. 1997, 51:868-872.
57. Ninomiya Y., Kagawa M., Iyama K., Naito I., Kishiro Y., Seyer J.M., Sugimoto M., Oohashi T., Sado Y. Differential expression of two basement membrane collagen genes, COL4A6 and COL4A5, demonstrated by immunofluorescence staining using peptide-specific monoclonal antibodies. J. Cell Biol. 1995, 130:1219-1229.
58. Norio R. Heredity in the congenital nephrotic syndrome: a genetic study of 57 Finnish families with a review of reported cases. Ann. Paediatr. Fenn. 1966, 12:27-34. (Suppl.).
59. Patrakka J., Ruotsalainen V., Qvist E., Laine J., Holmberg C., Tryggvason K., Jalanko H. Recurrence of nephrosis in kidney grafts of patients with congenital nephrosis (NPHS1): Role of nephrin. Transplantation 2001, 73:394-403.
60. Patrakka J., Kestilä M., Wartiovaara J., Ruotsalainen V., Tissari P., Lenkkeri U., Männikkö M., Visapää I., Holmberg C., Rapola J., Tryggvason K., Jalanko H. Congenital nephrotic syndrome of the Finnish type (NPHS1): Features resulting from different mutations in Finnish patients. Kidney Int. 2000, 58:972-980.
61. Peissel B., Geng L., Kalluri R., Kashtan C., Rennke H.G., Gallo G.R., Yoshioka K., Sun M.J., Hudson B.G., Neilson E.G., Zhou J. Comparative distribution of the α1(IV), α5(IV), and α6(IV) collagen chains in normal human adult and fetal tissues and in kidneys from X-linked Alport syndrome patients. J. Clin. Invest. 1995, 96:1948-1957.
62. Putaala H., Soininen R., Kilpeläinen P., Wartiovaara J., Tryggvason K. The murine nephrin gene is specifically expressed in kidney, brain, and pancreas: Inactivation of the gene leads to massive proteinuria and neonatal death. Hum. Mol. Genet. 2001, 10:1-8.
63. Putaala H., Sainio K., Sariola H., Tryggvason K. Primary structure of mouse and rat nephrin cDNA and structure and expression of the mouse gene. J. Am. Soc. Nephrol. 2000, 11:991-1001.
64. Qvist E., Laine J., Rönnholm K., Jalanko H., Leijala M., Holmberg C. Graft function 5-7 years after renal transplantation in early childhood. Transplantation 1999, 67:1043-1049.
65. Raats C.J., van den Born J., Berden J.H.M. Glomerular heparan sulfate alterations: Mechanisms and relevance for proteinuria. Kidney Int. 2000, 57:385-400.
66. Rodewald R., Karnoswky M.J. Porous structure of the glomerular slit diaphragm in the rat and mouse. J. Cell Biol. 1974, 60:423-433.
67. Ruotsalainen V., Ljungberg P., Wartiovaara J., Lenkkeri U., Kestilä M., Jalanko H., Holmberg C., Tryggvason K. Nephrin is specifically located at the slit diaphragm of glomerular podocytes. Proc. Natl. Acad. Sci. USA 1999, 96:7962-7967.
68. Ruotsalainen V., Patrakka J., Tissari P., Reponen P., Hess M., Kestilä M., Holmberg C., Salonen R., Heikinheimo M., Wartiovaara J., Tryggvason K., Jalanko H. Role of nephrin in cell junction formation in human nephrogenesis. Am. J. Pathol. 2000, 157:1905-1916.
69. Rutgers A., Meyers K.E., Canziani G., Kalluri R., Lin J., Madaio M. High affinity of anti-GBM antibodies from Goodpasture and transplanted Alport patients to α3(IV)NC1 collagen. Kidney Int. 2000, 58:115-122.
70. Salomon R., Gubler M.C., Niaudet P. Genetics of the nephrotic syndrome. Curr. Opin. Pediatr. 2000, 12:129-134.
71. Sayers R., Kalluri R., Rodgers K., Shield C., Meehan D., Cosgrove D. Role for transforming growth factor-β1 in Alport renal disease progression. Kidney Int. 1999, 56:1662-1673.
72. Shih N.Y., Karpitskii V., Nguyen A., Dustin M.L., Kanagawa O., Miner J., Shaw A.S. Congenital nephrotic syndrome in mice lacking CD2-associated protein. Science 1999, 286:312-315.
73. Smoyer W.E., Mundel P. Regulation of podocyte structure during the development nephrotic syndrome. J. Mol. Med. 1998, 76:172-183.
74. Somlo S., Mundel P. Getting a foothold in nephrotic syndrome. Nature Genet. 2000, 24:333-335.
75. Thorner P.S., Zheng K., Kalluri R., Jacobs R., Hudson B.G. Coordinate gene expression of the α3, α4 and α5 chains of collagen type IV: Evidence from a canine model of X-linked nephritis with a COL4A5 gene mutation. J. Biol. Chem. 1996, 271:13821-13828.
76. Tryggvason K. Unravaling the mechanism of glomerular ultrafiltration: Nephrin, a key component of the slit diaphragm. J. Am. Soc. Nephrol. 1999, 10:2440-2445.
77. Tryggvason K., Heikkilä P., Pettersson E., Tibell A., Thorner P. Can Alport syndrome be treated by gene therapy. Kidney Int. 1997, 51:1493-1499.
78. Tryggvason K., Kouvalainen K. Number of nephrons in normal human kidneys and kidneys of patients with the congenital nephrotic syndrome: A study using a sieving method for counting of glomeruli. Nephron 1975, 15:62-68.
79. van der Loop F., Heidet L., Timmer E., van den Bosch B., Leinonen A., Antignac C., Jefferson J., Maxwell A., Monnens L., Schröder C., Smeets H. Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation. Kidney Int. 2000, 58:1870-1875.
80. Wickelgren I. First components found for key kidney filter. Science 1999, 286:225-226.
81. Wing A.J., Brunner F.P. Twenty-three years of dialysis and transplantation in Europe: Experiences of the EDTA registry. Am. Kidney Dis. 1989, 14:341-346.
82. Yoshioka K., Hino S., Takemura T., Maki S., Wieslander J., Takekoshi Y., Makino H., Kagawa M., Sado Y., Kashtan C.E. Type IV collagen α5 chain: Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody. Am. J. Pathol. 1994, 144:986-996.
83. Zheng K., Thorner P., Marrano P., Baumal R., McInnes R.R. Canine X chromosome-linked hereditary nephritis: A genetic model for human X-linked hereditary nephritis resulting from a single base mutation in the gene encoding the α5 chain of collagen type IV. Proc. Natl. Acad. Sci. USA 1994, 91:3989-3993.
84. Zhou J., Leinonen A., Tryggvason K. Structure of the human type IV collagen COL4A5 gene. J. Biol. Chem. 1994, 269:6608-6614.